Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) — Stock Score Summary

Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) has a MoatMap StockRank of 70/100 based on Quality (66/100), Value (59/100), and Momentum (29/100) factor scores. The current signal is BUY. Despite being a CDMO, Jiuzhou faces severe geopolitical headwinds from the US Biosecure Act, which threatens to decouple Chinese CDMOs from Western biotech funding.

Zhejiang Jiuzhou Pharmaceutical is a leading Contract Development and Manufacturing Organization (CDMO) providing active pharmaceutical ingredients (APIs) and finished dosage forms to global pharma companies. The company boasts a strong competitive moat built on advanced chemical synthesis capabilities, strict global regulatory compliance, and deep integration with multinational pharmaceutical innovators. It is a key player in the global pharmaceutical supply chain, transitioning rapidly toward high-margin CDMO services.

Key Financial Metrics

Price$1.82
Market Cap$1.7B
P/E (TTM)16.96
P/E (Forward)12.14
Price/Book1.23
Return on Equity7.3%
Return on Invested Capital10.3%
Debt/Equity1.14
Gross Margin33.4%
Operating Margin19.7%
Revenue Growth-19.4%
Dividend Yield4.0%
Free Cash Flow$-8M

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s (603456.SS) StockRank?
MoatMap’s StockRank for Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) is 70/100, with a Buy signal. It is a composite of Quality (66), Value (59), and Momentum (29) factor ranks across MoatMap’s 19,000+ stock universe.
Does Zhejiang Jiuzhou Pharmaceutical Co., Ltd have an economic moat?
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Zhejiang Jiuzhou Pharmaceutical Co., Ltd a buy, hold, or sell?
MoatMap’s current signal for Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) is Buy, based on a StockRank of 70/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Zhejiang Jiuzhou Pharmaceutical Co., Ltd in?
Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks603456.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock